CompletedPhase 4NCT00743093
Aminotransferase Trends During Prolonged Acetaminophen Dosing
Studying Rare intoxication due to medical products
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Denver Health and Hospital Authority
- Principal Investigator
- Kennon Heard, MDDenver Health/Rocky Mountain Poison & Drug Center
- Intervention
- acetaminophen(drug)
- Enrollment
- 398 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2008 – 2011
Study locations (2)
- University of Colorado Health Sciences Center - GCRC, Aurora, Colorado, United States
- Denver Health Rocky Mountain Poison and Drug Center, Denver, Colorado, United States
Collaborators
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00743093 on ClinicalTrials.govOther trials for Rare intoxication due to medical products
Additional recruiting or active studies for the same condition.
See all trials for Rare intoxication due to medical products →